Livagen vs Ovagen

Overview

Livagen and Ovagen are both studied in the peptide research space.

Livagen: A synthetic tripeptide (Lys-Glu-Asp) developed by Russian scientist Vladimir Khavinson, claimed to support liver function and modulate hepatic gene expression.

Ovagen: A synthetic tripeptide (Glu-Asp-Leu) developed by Russian scientist Vladimir Khavinson for liver support.

Evidence Comparison

Aspect	Livagen	Ovagen
Evidence Level	Low	Low
Human Studies	2	1
Preclinical Studies	8	8
Total Sources	12	10

Key Differences

Aspect	Livagen	Ovagen
Category	Other	Other
Evidence Strength	Low	Low
Total Sources	12	10
Human Studies	2	1

Summary

• Livagen: Low evidence with 12 total sources (2 human)
• Ovagen: Low evidence with 10 total sources (1 human)

---

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.